The estimated Net Worth of Deborah G Ellinger is at least $2.12 millió dollars as of 13 June 2022. Ms. Ellinger owns over 730 units of Covetrus stock worth over $544,753 and over the last 13 years she sold CVET stock worth over $1,272,795. In addition, she makes $305,000 as Independent Director at Covetrus.
Sign up
Ms. Ellinger CVET stock SEC Form 4 insiders trading
Deborah has made over 8 trades of the Covetrus stock since 2013, according to the Form 4 filled with the SEC. Most recently she sold 730 units of CVET stock worth $28,382 on 13 June 2022.
The largest trade she's ever made was exercising 24,089 units of Covetrus stock on 13 May 2021 worth over $505,628. On average, Deborah trades about 1,506 units every 108 days since 2011. As of 13 June 2022 she still owns at least 25,953 units of Covetrus stock.
You can see the complete history of Ms. Ellinger stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Deborah Ellinger biography
Deborah G. Ellinger is Independent Director of the Company. Ms. Ellinger is currently a Senior Advisor for The Boston Consulting Group (“BCG”), a consulting firm, a Director of iRobot Corp, a technology company, and is the former CEO or President of four private-equity backed firms. She has been a Senior Advisor to BCG since June 2018, working primarily with their private equity team, and has served on the iRobot Board since 2011, where she is also Chair of the nominating and governance committee and has sat on several other Board committees. Her leadership roles include: President and Chief Executive Officer of Ideal Image, a chain of 130 Medical Spas, from 2016 to 2018; Chairman and Chief Executive Officer of The Princeton Review, a test preparation company, from 2012 to 2014; President of Restoration Hardware from 2008 to 2009, and President and Chief Executive Officer of Wellness Pet Food from 2004 to 2008. Previously, she served as an Executive Vice President at CVS Pharmacy, a Senior Vice President at Staples, Inc., and was a partner at The Boston Consulting Group; she began her career with Mellon Financial Corporation. Ms. Ellinger has extensive additional Board experience: from 2015 to 2017, she served as a Director of Interpublic Group of Companies, sitting on the audit committee, compensation committee and finance committees at different times. She was also a member of the Board of Directors of National Life Group from 2007 to 2014 and served on its executive committee, audit committee and was Chair of its nominating and governance committee. She served on the Board of Sealy, Inc. from 2010 to 2013, where she was a member of the compensation committee and audit committee. She has also sat on the boards of several private companies since 2004. Ms. Ellinger’s assignments have taken her all over the world; she has lived and worked in Europe, Asia and the United States. She holds an M.A. and B.A. in Law and Mathematics from the University of Cambridge, England.
What is the salary of Deborah Ellinger?
As the Independent Director of Covetrus, the total compensation of Deborah Ellinger at Covetrus is $305,000. There are 12 executives at Covetrus getting paid more, with Benjamin Wolin having the highest compensation of $4,065,210.
How old is Deborah Ellinger?
Deborah Ellinger is 61, she's been the Independent Director of Covetrus since 2019. There are 4 older and 20 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
What's Deborah Ellinger's mailing address?
Deborah's mailing address filed with the SEC is C/O IROBOT CORPORATION, 8 CROSBY DRIVE, BEDFORD, MA, 01730.
Insiders trading at Covetrus
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin és Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
What does Covetrus do?
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
What does Covetrus's logo look like?
Complete history of Ms. Ellinger stock trades at Irobot Corp, Interpublic Of Cos, Tupperware Brands és Covetrus
Covetrus executives and stock owners
Covetrus executives and other stock owners filed with the SEC include:
-
Benjamin Wolin,
President, Chief Executive Officer, Director -
Dustin Finer,
Chief Administrative Officer -
Georgina Wraight,
Executive Vice President, President - Global Technology Solutions -
Benjamin Wolin,
CEO, Pres & Director -
Georgina Wraight,
Exec. VP & Pres of Global Technology Solutions -
Matthew J. Foulston,
Exec. VP & Global CFO -
Philip Laskawy,
Independent Chairman of the Board -
Dustin k. Finer,
Chief Admin. Officer -
Sandra Helton,
Independent Director -
Ravi Sachdev,
Independent Director -
Edward McNamara,
Independent Director -
Mark Manoff,
Independent Director -
Deborah Ellinger,
Independent Director -
Steven Paladino,
Director -
Nicholas Jansen,
Vice President of Investor Relations -
Sandra Peterson,
Director -
Arman Samani,
Chief Product Officer -
Steve Palmucci,
Global Chief Information Officer -
Laura Phillips,
Chief Accounting Officer, Vice President, Global Controller -
Erin Brennan,
Senior Vice President, General Counsel, Secretary -
Anthony Providenti,
Executive Vice President, Corporate Development -
Timothy Ludlow,
Executive Vice President, Chief Transformation Officer -
David Hinton,
Executive Vice President, President - APAC and Emerging Marke -
Michael Ellis,
Executive Vice President, President - Europe and North America -
Matthew Malenfant,
President, Customer Operations - North America -
Matthew Foulston,
Global Chief Financial Officer -
Russell Cooke,
Sr. VP & Operational CFO -
Ditte Marstrand Wulf,
Global Chief HR Officer -
Kini Schoop,
Director of PR -
Andrew B. Coxhead,
VP, Corp. Controller & Chief Accounting Officer -
Bekki Kidd,
Head of Operations & Operational Excellence -
Kinà Schoop,
Director of PR -
Jamey S. Seely,
Gen. Counsel & Corp. Sec. -
Paul R. Fonteyne,
Director -
Andrew B. Coxhead,
See Remarks -
Benjamin Shaw,
Chief Executive Officer -
Investment Associates Ix, L...,
-
Christine T Komola,
See Remarks -
Sharon L Wienbar,
Director -
Jamey S Seely,
General Counsel and Secretary -
David Christopher Dollar,
See Remarks -
Rebecca Ann Kidd,
Head of Global Operations